Lydie Lemonnier

Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France

Anne‐Laure Roux, Émilie Catherinot, Fabienne Neulat-Ripoll et al. · Journal of Clinical Microbiology · 2009 · 306 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 235 citations

Medicine, Pharmacotherapy, Pulmonary Function Testing +15

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 132 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations

Émilie Catherinot, Anne‐Laure Roux, Marie‐Anne Vibet et al. · Journal of Cystic Fibrosis · 2012 · 105 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +9

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

Clémence Martin, Cécile Hamard, Reem Kanaan et al. · Journal of Cystic Fibrosis · 2015 · 102 citations

Medicine, Surgery, Clinical Epidemiology +7